CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-07 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −786 | $141.35 | $111K | 20,955 |
| 2025-02-07 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +2,216 | 23,171 | ||
| 2025-02-07 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −716 | $141.35 | $101K | 22,455 |
| 2025-02-07 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,335 | 2,335 | ||
| 2025-02-07 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,216 | 4,434 | ||
| 2025-02-07 | Viehbacher Christopher President and CEO | Option exercise | +9,008 | 16,008 | ||
| 2025-02-07 | Viehbacher Christopher President and CEO | Shares withheld for taxes | −3,201 | $141.35 | $452K | 12,807 |
| 2025-02-07 | Viehbacher Christopher President and CEO | Option exercise · Restricted Stock Unit | −9,008 | 18,017 | ||
| 2025-02-07 | Grogan Jane Head of Research | Option exercise | +1,385 | 1,876 | ||
| 2025-02-07 | Grogan Jane Head of Research | Shares withheld for taxes | −443 | $141.35 | $63K | 1,433 |
| 2025-02-07 | Grogan Jane Head of Research | Option exercise · Restricted Stock Unit | −1,385 | 2,770 | ||
| 2025-02-07 | Keeney Adam Head of Corporate Development | Option exercise | +1,801 | 2,463 | ||
| 2025-02-07 | Keeney Adam Head of Corporate Development | Shares withheld for taxes | −563 | $141.35 | $80K | 1,900 |
| 2025-02-07 | Keeney Adam Head of Corporate Development | Option exercise · Restricted Stock Unit | −1,801 | 3,604 | ||
| 2025-02-07 | Kramer Robin Chief Accounting Officer | Option exercise | +788 | 7,195.75 | ||
| 2025-02-07 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −232 | $141.35 | $33K | 6,963.75 |
| 2025-02-07 | Kramer Robin Chief Accounting Officer | Option exercise | +703 | 7,666.75 | ||
| 2025-02-07 | Kramer Robin Chief Accounting Officer | Shares withheld for taxes | −244 | $141.35 | $34K | 7,422.75 |
| 2025-02-07 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −788 | 789 | ||
| 2025-02-07 | Kramer Robin Chief Accounting Officer | Option exercise · Restricted Stock Unit | −703 | 1,407 |
Page 10 of 29 · 579 trades